These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bladder cancer. Gwynn ES; Clark PE Curr Opin Oncol; 2006 May; 18(3):277-83. PubMed ID: 16552241 [TBL] [Abstract][Full Text] [Related]
3. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony]. Steinbach F; Schuster F Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of bladder cancer. Sharma S; Ksheersagar P; Sharma P Am Fam Physician; 2009 Oct; 80(7):717-23. PubMed ID: 19817342 [TBL] [Abstract][Full Text] [Related]
5. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder. Pham HT; Soloway MS Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909 [TBL] [Abstract][Full Text] [Related]
6. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary? Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448 [TBL] [Abstract][Full Text] [Related]
7. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480 [TBL] [Abstract][Full Text] [Related]
8. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group. Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805 [TBL] [Abstract][Full Text] [Related]
9. Prostatic urothelial carcinoma: is transurethral prostatectomy necessary before bacillus Calmette-Guérin immunotherapy? Gofrit ON; Pode D; Pizov G; Zorn KC; Katz R; Shapiro A BJU Int; 2009 Apr; 103(7):905-8. PubMed ID: 19021623 [TBL] [Abstract][Full Text] [Related]
15. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439 [TBL] [Abstract][Full Text] [Related]
16. [BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study]. Jocham D; von Wietersheim J; Pflüger H; Steiner H; Doehn C; Büttner H; Böhle A; Kausch I Aktuelle Urol; 2009 Mar; 40(2):91-9. PubMed ID: 19214951 [TBL] [Abstract][Full Text] [Related]
17. The limits of bacillus Calmette-Guerin for carcinoma in situ of the bladder. Kim JC; Steinberg GD J Urol; 2001 Mar; 165(3):745-56. PubMed ID: 11176460 [TBL] [Abstract][Full Text] [Related]
18. T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin. Volkmer BG; Gschwend JE; Maier SH; Seidl-Schlick EM; Bach D; Romics I J Urol; 2003 Mar; 169(3):931-4; discussion 934-5. PubMed ID: 12576815 [TBL] [Abstract][Full Text] [Related]
19. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients. Peyromaure M; Guerin F; Amsellem-Ouazana D; Saighi D; Debre B; Zerbib M J Urol; 2003 Jun; 169(6):2110-2. PubMed ID: 12771729 [TBL] [Abstract][Full Text] [Related]
20. Reassessment of conservative management for stage T1N0M0 transitional cell carcinoma of the bladder. Zhang GK; Uke ET; Sharer WC; Borkon WD; Bernstein SM J Urol; 1996 Jun; 155(6):1907-9. PubMed ID: 8618284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]